$2.61
arrow_drop_down0.76%Key Stats | |
---|---|
Open | $2.59 |
Prev. Close | $2.63 |
EPS | -0.61 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $67.60M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 2.55 | 2.70 |
52 Week Range | 1.81 | 3.85 |
Ratios | |
---|---|
EPS | -0.61 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
InspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard™ Prime Carotid Stent System
InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial of CGuard at LINC 2024
Shockwave Medical (SWAV) Q1 Earnings and Revenues Top Estimates
InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024
InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
InspireMD's (NSPR) CE Mark Recertification to Boost CGuard EPS